When it comes to Big Pharma, the likes of Novartis, Bristol Myers Squibb and AstraZeneca have Bluesky accounts — though none ...

Squibb announced that the U.S. Food and Drug Administration has updated the U.S. Prescribing Information for Camzyos, ...

BofA lowered the firm’s price target on Bristol Myers (BMY) to $58 from $63 and keeps a Neutral rating on the shares. For Q1, the firm’s total ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Bristol Myers Squibb pays investors a very attractive dividend that yields 4.1%. The company reported a loss last year, but that was a result of non-recurring expenses. Free cash flow looked ...

Bristol Myers has built a reputation for beating earnings expectations like it’s allergic to underperformance. The biopharma giant has outpaced consensus estimates in the last two quarters, averaging ...

A federal appeals court on Tuesday affirmed the dismissal of a dental surgeon’s suit alleging Bristol-Myers Squibb Co.'s leukemia drug Sprycel caused retinal bleeding and vision loss. The surgeon didn ...

As you can see from the chart above the percentage of shares that are sold short for Bristol-Myers Squibb has grown since its last report. This does not mean that the stock is going to fall in the ...

Bristol Myers Squibb announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of a new Opdivo (nivolumab) formulation ...

It’s not HBO, it’s Max — but the new standalone logo for Warner Bros. Discovery‘s streamer now certainly looks like HBO’s at a glance. The Max streaming service has quietly launched a ...